Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 5/20 | 0.35 |
| ▸ | HTR1B | P28222 | 1/20 | 0.34 |
| ▸ | HTR2B | P41595 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 4/20 | 0.33 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.33 |
| ▸ | HTR3B | O95264 | 1/20 | 0.33 |
| ▸ | HTR3A | P46098 | 1/20 | 0.33 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.33 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CD38 | P28907 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17730372 | 1.00 | HSD11B1 (0.35) | HSD11B1HTR1BHTR2BCNR2HTR3E | |
| SCHEMBL19629455 | 1.00 | HSD11B1 (0.35) | HSD11B1HTR1BHTR2BCNR2HTR3E | |
| SCHEMBL17730370 | 1.00 | HSD11B1 (0.35) | HSD11B1HTR1BHTR2BCNR2HTR3E | |
| SCHEMBL23490414 | 1.00 | HSD11B1 (0.35) | HSD11B1HTR1BHTR2BCNR2HTR3E | |
| SCHEMBL17730373 | 1.00 | HSD11B1 (0.35) | HSD11B1HTR1BHTR2BCNR2HTR3E | |
| SCHEMBL23490715 | 1.00 | HSD11B1 (0.35) | HSD11B1HTR1BHTR2BCNR2HTR3E | |
| SCHEMBL19438199 | 0.89 | HSD11B1 (0.41) | HSD11B1CNR2KDM4EALDH1A1CD38 | |
| SCHEMBL19681757 | 0.89 | HSD11B1 (0.41) | HSD11B1CNR2HTR3EHTR3BHTR3A | |
| SCHEMBL23901462 | 0.89 | HSD11B1 (0.41) | HSD11B1CNR2KDM4EALDH1A1CD38 | |
| SCHEMBL20938467 | 0.89 | HSD11B1 (0.41) | HSD11B1CNR2KDM4EALDH1A1CD38 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10786508-B2 | Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders | LYSOSOMAL THERAPEUTICS INC. (US) | 2020-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10786508-B2 | Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders | GBA1, GAA, SNCA | HSD11B1 4513/4885HTR1B 1264/4885HTR2B 2346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.